BICO Group AB (publ) (CLLKF) Stock Price, News & Analysis

Company Overview

BICO Group AB (publ), formerly known as CELLINK, is a Sweden-based life science technology company focused on bioconvergence—the integration of biology with engineering, automation, and computational technologies. The company develops tools and systems intended to support pharmaceutical research, diagnostics, regenerative medicine, and other applications in the life sciences.

BICO’s products and services have included 3D bioprinters, bioinks, laboratory automation equipment, precision instruments, imaging and analysis software, and technologies for multiomics and cell-based research. Its solutions are designed to help researchers create, process, analyze, and reproduce biological models and laboratory workflows, including applications related to drug discovery and personalized medicine.

The company was founded in 2016 under the CELLINK name and changed its name to BICO Group in 2021. Through its operating businesses and brands, BICO has served pharmaceutical and biotechnology companies, academic institutions, healthcare organizations, and research laboratories in markets around the world. The company is headquartered in Gothenburg, Sweden.

Key Stats

• Today's Range: C$2.15 to C$2.15
• 50-Day Range: C$1.53 to C$2.26
• 52-Week Range: C$1.52 to C$2.73
• Volume: N/A
• Average Volume: 7,950 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CLLKF
• CIK: N/A
• Web: bico.com
• Phone: (463) 112-8700
• Fax: N/A
• Employees: 695
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A